FDA approves new multiple myeloma drug despite toxicity concerns
The Food and Drug Administration on Wednesday approved a new drug to treat patients with multiple myeloma, overruling a panel of outside cancer experts who expressed concerns about its toxicity.
The new multiple myeloma drug, called selinexor, will be marketed by Karyopharm Therapeutics under the brand name Xpovio.
Read Original Article: FDA approves new multiple myeloma drug despite toxicity concerns »
